{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F16e295c8-bcb5-4c9c-b0f9-d882dfe8b747","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"HER2-Low and HER2-Ultralow Breast Cancer \u2014 San Antonio 2024 symposium series proceedings Part 1\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/16e295c8-bcb5-4c9c-b0f9-d882dfe8b747\"></iframe>","title":"HER2-Low and HER2-Ultralow Breast Cancer \u2014 San Antonio 2024 symposium series proceedings Part 1","description":"Featuring a discussion on data from SABCS 2024 and the management of HER2-low breast cancer with Drs Bardia, Curigliano, Rugo and Wolff, moderated by Dr Neil Love. Produced by Research To Practice.\r\n\n\nCME information and select publications https://www.researchtopractice.com/SABCS2024/HER2LowBC (here)\r\n","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/69828539-7278-4573-b4e7-9fe7e816ef3b/cover.jpg"}